Macroaxis uses a strict editorial review process to publish stories and blog posts. Our publishers support our company and may receive a small commission when the partner links or references are utilized. Commissions do not affect the opinions or evaluations of our editorial team. The information our editors and media partners deliver is confidential and licensed for your sole use as a Macroaxis user. We reserve all rights to the content of this article, and therefore copying or distributing this story in whole or in part is strictly prohibited.
This list of potential positions covers Companies that count on Obamacare to take off. Health care services and providers including hospitals, clinics and nursing homes that hope to benefit from Obamacare program in USA. Please note, we provide buy hold or sell recommendation only in the context of selected investment horizon assuming investor has average attitude towards taking risk. Please also consider using Portfolio Positions Ratings and Equity Ratings tools to further calibrate your research.
Story appears to be empty
Select Medical Holdings (SEM)
The company has Return on Asset of 0.0452 % which means that on every $100 spent on assets, it made $0.0452 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.2022 %, implying that it generated $0.2022 on every 100 dollars invested. Select Medical's management efficiency ratios could be used to measure how well Select Medical manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Select Medical's Return On Capital Employed is very stable compared to the past year. As of the 19th of April 2024, Return On Equity is likely to grow to 0.20, while Return On Tangible Assets are likely to drop 0.06. At this time, Select Medical's Asset Turnover is very stable compared to the past year. The firm currently falls under 'Mid-Cap' category with a total capitalization of 3.5 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Select Medical's market, we take the total number of its shares issued and multiply it by Select Medical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. At this time, the company appears to be undervalued. Select Medical Holdings has a current Real Value of $32.35 per share. The regular price of the company is $26.43. Our model measures the value of Select Medical Holdings from inspecting the company fundamentals such as Return On Equity of 0.2, operating margin of 0.07 %, and Shares Outstanding of 128.36 M as well as reviewing its technical indicators and probability of bankruptcy. In general, most investors recommend obtaining undervalued stocks and abandoning overvalued stocks since, at some point, asset prices and their ongoing real values will draw towards each other.
Tenet Healthcare (THC)
The company has Return on Asset of 0.0629 % which means that on every $100 spent on assets, it made $0.0629 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.2592 %, implying that it generated $0.2592 on every 100 dollars invested. Tenet Healthcare's management efficiency ratios could be used to measure how well Tenet Healthcare manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to 0.04. The current year's Return On Capital Employed is expected to grow to 0.12. At present, Tenet Healthcare's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 209.6 M, whereas Intangible Assets are forecasted to decline to about 1.4 B. This firm currently falls under 'Mid-Cap' category with a total capitalization of 9.03 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Tenet Healthcare's market, we take the total number of its shares issued and multiply it by Tenet Healthcare's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.
Short Long Term Debt Total
17.02 Billion
At present, Tenet Healthcare's Short and Long Term Debt Total is projected to increase significantly based on the last few years of reporting.
HMS Holdings Corp (HMSY)
The company has return on total asset (ROA) of 4.53 % which means that it generated a profit of $4.53 on every $100 spent on assets. This is normal as compared to the sector avarege. Similarly, it shows a return on stockholder's equity (ROE) of 7.78 %, meaning that it created $7.78 on every $100 dollars invested by stockholders. HMS Holdings' management efficiency ratios could be used to measure how well HMS Holdings manages its routine affairs as well as how well it operates its assets and liabilities. The firm currently falls under 'Mid-Cap' category with a current market capitalization of 3.29 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate HMS Holdings's market, we take the total number of its shares issued and multiply it by HMS Holdings's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.
Endologix (ELGX)
The entity beta is close to zero. As returns on the market increase, Endologix's returns are expected to increase less than the market. However, during the bear market, the loss of holding Endologix is expected to be smaller as well. The beta indicator helps investors understand whether Endologix moves in the same direction as the rest of the market, and how volatile (i.e., risky) it is compared to the market (i.e., selected benchmark). In other words, if Endologix deviates very little from the market, it does not add much risk to the portfolio, but it also doesn't increase the expected returns. This firm currently falls under 'Nano-Cap' category with a current market capitalization of 4.22 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Endologix's market, we take the total number of its shares issued and multiply it by Endologix's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.
ABIOMED (ABMD)
The company has return on total asset (ROA) of 0.0955 % which means that it generated a profit of $0.0955 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1824 %, meaning that it created $0.1824 on every $100 dollars invested by stockholders. ABIOMED's management efficiency ratios could be used to measure how well ABIOMED manages its routine affairs as well as how well it operates its assets and liabilities. This firm currently falls under 'Large-Cap' category with a current market capitalization of 17.18 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate ABIOMED's market, we take the total number of its shares issued and multiply it by ABIOMED's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.
NuVasive (NUVA)
The company has return on total asset (ROA) of 0.0242 % which means that it generated a profit of $0.0242 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0331 %, meaning that it created $0.0331 on every $100 dollars invested by stockholders. NuVasive's management efficiency ratios could be used to measure how well NuVasive manages its routine affairs as well as how well it operates its assets and liabilities. The entity currently falls under 'Mid-Cap' category with a current market capitalization of 2.08 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate NuVasive's market, we take the total number of its shares issued and multiply it by NuVasive's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.
Globus Medical (GMED)
The company has return on total asset (ROA) of 0.0477 % which means that it generated a profit of $0.0477 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0421 %, meaning that it created $0.0421 on every $100 dollars invested by stockholders. Globus Medical's management efficiency ratios could be used to measure how well Globus Medical manages its routine affairs as well as how well it operates its assets and liabilities. As of April 19, 2024, Return On Tangible Assets is expected to decline to 0.04. In addition to that, Return On Capital Employed is expected to decline to 0.03. At present, Globus Medical's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 82.5 M, whereas Return On Tangible Assets are forecasted to decline to 0.04. The entity currently falls under 'Mid-Cap' category with a current market capitalization of 6.87 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Globus Medical's market, we take the total number of its shares issued and multiply it by Globus Medical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. At this time, the firm appears to be fairly valued. Globus Medical retains a regular Real Value of $52.17 per share. The prevalent price of the firm is $50.75. Our model calculates the value of Globus Medical from evaluating the firm fundamentals such as Return On Asset of 0.0477, current valuation of 6.87 B, and Return On Equity of 0.0421 as well as inspecting its technical indicators and probability of bankruptcy. In general, most investors encourage purchasing undervalued assets and exiting overvalued assets since, at some point, asset prices and their ongoing real values will come together.
Macroaxis financial leverage refers to using borrowed capital as a funding source to finance Macroaxis ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. Macroaxis financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Financial leverage can amplify the potential profits to Macroaxis' owners, but it also increases the potential losses and risk of financial distress, including bankruptcy, if the firm cannot cover its debt costs. The degree of Macroaxis' financial leverage can be measured in several ways, including by ratios such as the debt-to-equity ratio (total debt / total equity), equity multiplier (total assets / total equity), or the debt ratio (total debt / total assets). Please check the breakdown between Macroaxis's total debt and its cash.
Macroaxis Gross Profit
Macroaxis Gross Profit growth is one of the most critical measures in evaluating the company. The Gross Profit growth rate is calculated simply by comparing Macroaxis previous period's values with its current period's values. Each time period you're measuring should be of equal lengths the increase or decrease, in a company's Gross Profit between two periods. Here we show Macroaxis Gross Profit growth over the last 10 years. Please check Macroaxis' gross profit and other fundamental indicators for more details.
Story appears to be empty
Select Medical Holdings (SEM)
The company has Return on Asset of 0.0452 % which means that on every $100 spent on assets, it made $0.0452 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.2022 %, implying that it generated $0.2022 on every 100 dollars invested. Select Medical's management efficiency ratios could be used to measure how well Select Medical manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Select Medical's Return On Capital Employed is very stable compared to the past year. As of the 19th of April 2024, Return On Equity is likely to grow to 0.20, while Return On Tangible Assets are likely to drop 0.06. At this time, Select Medical's Asset Turnover is very stable compared to the past year. The firm currently falls under 'Mid-Cap' category with a total capitalization of 3.5 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Select Medical's market, we take the total number of its shares issued and multiply it by Select Medical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. At this time, the company appears to be undervalued. Select Medical Holdings has a current Real Value of $32.35 per share. The regular price of the company is $26.43. Our model measures the value of Select Medical Holdings from inspecting the company fundamentals such as Return On Equity of 0.2, operating margin of 0.07 %, and Shares Outstanding of 128.36 M as well as reviewing its technical indicators and probability of bankruptcy. In general, most investors recommend obtaining undervalued stocks and abandoning overvalued stocks since, at some point, asset prices and their ongoing real values will draw towards each other.
Tenet Healthcare (THC)
The company has Return on Asset of 0.0629 % which means that on every $100 spent on assets, it made $0.0629 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.2592 %, implying that it generated $0.2592 on every 100 dollars invested. Tenet Healthcare's management efficiency ratios could be used to measure how well Tenet Healthcare manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to 0.04. The current year's Return On Capital Employed is expected to grow to 0.12. At present, Tenet Healthcare's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 209.6 M, whereas Intangible Assets are forecasted to decline to about 1.4 B. This firm currently falls under 'Mid-Cap' category with a total capitalization of 9.03 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Tenet Healthcare's market, we take the total number of its shares issued and multiply it by Tenet Healthcare's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.
Short Long Term Debt Total
17.02 Billion
At present, Tenet Healthcare's Short and Long Term Debt Total is projected to increase significantly based on the last few years of reporting.
HMS Holdings Corp (HMSY)
The company has return on total asset (ROA) of 4.53 % which means that it generated a profit of $4.53 on every $100 spent on assets. This is normal as compared to the sector avarege. Similarly, it shows a return on stockholder's equity (ROE) of 7.78 %, meaning that it created $7.78 on every $100 dollars invested by stockholders. HMS Holdings' management efficiency ratios could be used to measure how well HMS Holdings manages its routine affairs as well as how well it operates its assets and liabilities. The firm currently falls under 'Mid-Cap' category with a current market capitalization of 3.29 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate HMS Holdings's market, we take the total number of its shares issued and multiply it by HMS Holdings's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.
Endologix (ELGX)
The entity beta is close to zero. As returns on the market increase, Endologix's returns are expected to increase less than the market. However, during the bear market, the loss of holding Endologix is expected to be smaller as well. The beta indicator helps investors understand whether Endologix moves in the same direction as the rest of the market, and how volatile (i.e., risky) it is compared to the market (i.e., selected benchmark). In other words, if Endologix deviates very little from the market, it does not add much risk to the portfolio, but it also doesn't increase the expected returns. This firm currently falls under 'Nano-Cap' category with a current market capitalization of 4.22 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Endologix's market, we take the total number of its shares issued and multiply it by Endologix's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.
ABIOMED (ABMD)
The company has return on total asset (ROA) of 0.0955 % which means that it generated a profit of $0.0955 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1824 %, meaning that it created $0.1824 on every $100 dollars invested by stockholders. ABIOMED's management efficiency ratios could be used to measure how well ABIOMED manages its routine affairs as well as how well it operates its assets and liabilities. This firm currently falls under 'Large-Cap' category with a current market capitalization of 17.18 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate ABIOMED's market, we take the total number of its shares issued and multiply it by ABIOMED's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.
NuVasive (NUVA)
The company has return on total asset (ROA) of 0.0242 % which means that it generated a profit of $0.0242 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0331 %, meaning that it created $0.0331 on every $100 dollars invested by stockholders. NuVasive's management efficiency ratios could be used to measure how well NuVasive manages its routine affairs as well as how well it operates its assets and liabilities. The entity currently falls under 'Mid-Cap' category with a current market capitalization of 2.08 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate NuVasive's market, we take the total number of its shares issued and multiply it by NuVasive's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.
Globus Medical (GMED)
The company has return on total asset (ROA) of 0.0477 % which means that it generated a profit of $0.0477 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0421 %, meaning that it created $0.0421 on every $100 dollars invested by stockholders. Globus Medical's management efficiency ratios could be used to measure how well Globus Medical manages its routine affairs as well as how well it operates its assets and liabilities. As of April 19, 2024, Return On Tangible Assets is expected to decline to 0.04. In addition to that, Return On Capital Employed is expected to decline to 0.03. At present, Globus Medical's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 82.5 M, whereas Return On Tangible Assets are forecasted to decline to 0.04. The entity currently falls under 'Mid-Cap' category with a current market capitalization of 6.87 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Globus Medical's market, we take the total number of its shares issued and multiply it by Globus Medical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. At this time, the firm appears to be fairly valued. Globus Medical retains a regular Real Value of $52.17 per share. The prevalent price of the firm is $50.75. Our model calculates the value of Globus Medical from evaluating the firm fundamentals such as Return On Asset of 0.0477, current valuation of 6.87 B, and Return On Equity of 0.0421 as well as inspecting its technical indicators and probability of bankruptcy. In general, most investors encourage purchasing undervalued assets and exiting overvalued assets since, at some point, asset prices and their ongoing real values will come together.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Rifka Kats is a Member of Macroaxis Editorial Board. Rifka writes about retail product and service companies from the perspective of a regular consumer and sophisticated investor at the same time. She is passionate about corporate ethics and equality in the workforce. View Profile
This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Please refer to our Terms of Use for any information regarding our disclosure principles.
Would you like to provide feedback on the content of this article?
You can get in touch with us directly or send us a quick note via email to editors@macroaxis.com
Did you try this?
Run Sign In To Macroaxis Now
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any private could be tightly coupled with the direction of predictive economic indicators such as signals in persons. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
